Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Ciclopirox olamine 8% solution |
Is a |
Product containing ciclopirox (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Ciclopirox olamine 8% solution |
Is a |
Product containing precisely ciclopirox 80 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
false |
Inferred relationship |
Some |
|
|
Ciclopirox olamine 8% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Some |
|
|
Ciclopirox olamine 8% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Skin antifungal agent |
false |
Inferred relationship |
Some |
|
|
Ciclopirox olamine 8% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ciclopirox olamine |
false |
Inferred relationship |
Some |
|
|
Ciclopirox olamine 8% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Some |
|
|
Ciclopirox olamine 8% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent cutané |
false |
Inferred relationship |
Some |
|
|
Ciclopirox olamine 8% solution |
Has manufactured dose form |
forme pharmaceutique pour usage transdermique et/ou cutané |
false |
Inferred relationship |
Some |
|
|
Ciclopirox olamine 8% solution |
Has manufactured dose form |
Cutaneous solution |
false |
Inferred relationship |
Some |
|
|